Aetna is fined by New York for leaking members' HIV status

Published 01/23/2018, 04:11 PM
Updated 01/23/2018, 04:20 PM
© Reuters. A logo of Aetna is displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York
AET
-
CVS
-

By Jonathan Stempel

NEW YORK (Reuters) - Aetna Inc (NYSE:AET) will pay a $1.15 million civil fine and improve its privacy practices to settle charges that it leaked the HIV-positive status of 2,460 New York members in a mailing where it used envelopes with large transparent windows.

New York Attorney General Eric Schneiderman on Tuesday said names, addresses, claim numbers and HIV medication instructions in the July 28, 2017 mailing were "clearly visible" to outsiders because of how Aetna folded letters and inserted them into the envelopes.

The mailing was intended to notify members of a class action settlement permitting them to buy HIV medication at brick-and-mortar pharmacies rather than by mail, where their privacy might be compromised if neighbors or family saw the drug packages.

While about 1 million Americans live with HIV or AIDS, the associated stigma can lead to a denial of proper healthcare, discrimination and other negative consequences, according to settlement papers signed by Aetna and Schneiderman's office.

"Through its own carelessness, Aetna blatantly violated its promise to safeguard members' private health information," the attorney general said in a statement.

Schneiderman said his office uncovered similar issues with a Sept. 25, 2017 mailing by Aetna to 163 New York members with atrial fibrillation, an irregular heartbeat condition.

The Hartford, Connecticut-based company did not admit or deny wrongdoing, and agreed to retain an independent consultant for two years to monitor its efforts to improve member privacy.

It agreed last week to a $17.2 million settlement in the federal court in Philadelphia of private litigation over similar claims by more than 11,000 members in New York and other states.

"We have worked to address the potential impact to members following this unfortunate incident," Aetna said in a statement. "We are implementing measures designed to ensure something like this does not happen again as part of our commitment to best practices in protecting sensitive health information."

Aetna agreed last month to be bought by CVS Health Corp (NYSE:CVS) in a $69 billion transaction.

© Reuters. A logo of Aetna is displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York

HIV is short for human immunodeficiency virus, and AIDS for Acquired Immunodeficiency Syndrome.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.